This message was sent to ##Email##
|
|
|
|
|
| |
CDC
CDC encourages hospitals to take action, advises patients to seek care if ill
The CDC is actively working to address concerns related to contaminated heater-cooler units used during open heart surgery. There is a potential risk of infection from certain devices used during these surgeries due to bacterial contamination suspected to have been introduced during manufacturing. The bacteria, Mycobacterium chimaera, is a species of nontuberculous mycobacterium (NTM) often found in soil and water. In the environment, M. chimaera rarely makes healthy people sick.
To learn additional details about this concern, click here.
ASN
Join ASN and more than 13,000 other kidney professionals from across the globe at Kidney Week 2016 in Chicago, IL. The world's premier nephrology meeting, Kidney Week provides participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field. Visit the ASN website for more details and to register. The November 2 deadline for advanced registration is coming soon. Don't miss an opportunity to participate in this meeting.
AST
The AST Transplantation and Immunology Research Network (TIRN) research grants program funds innovative research in basic, clinical, and translational science. A limited number of grants will be awarded for research projects beginning July 1, 2017. The request for proposals is open now at www.TIRN.org/funding.
AST
The nomination submission website for the 2017 AST Board of Directors is now open and accepting applications. AST recognizes the importance of electing strong leaders and encourages nominations from qualified AST members. Detailed information and the nomination criteria can be found here.
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
AST
Oct. 26, 2016 1 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/optimizing-your-living-kidney-donor-program-1
AST
November 15, 2016 2 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/t3
Register today!
BeST16 Basic Science in Transplantation
The basic science community within our field is a tight-knit, dynamic group that benefits greatly from dedicated meeting opportunities to share knowledge and establish collaborations. As such, we hope you will join us at BeST16: Basic Science in Transplantation, a meeting jointly sponsored by the AST and ESOT.
HOUSING IS NOW OPEN
CEOT
The deadline to submit abstracts is Friday, November 18, 2016. To find out how to submit an abstract, please click here.
ATC
The American Transplant Congress is designed for physicians, surgeons, scientists, nurses, organ procurement personnel and pharmacists who are interested in the clinical and research aspects of solid organ and tissue transplantation. The meeting will provide the most current information in the field of transplant science. The deadline to submit abstracts is Friday, Dec. 2, 2016. For more information regarding abstract submission, please click here.
United Network for Organ Sharing
James Pittman, AVP of Transplant Services at Hospital Corporation of America (HCA) and a former transplant administrator/coordinator, knows firsthand how challenging it can be to keep a hospital’s kidney waiting list up-to-date, while juggling multiple priorities. Currently, transplant professionals can generate waiting list reports in UNet to help them with this burdensome task, but these reports are not easy to find or use.
READ MORE
ResearchGate
Among adult kidney transplant recipients, non-adherence to immunosuppressive medications is the leading predictor of poor outcomes, including rejection, kidney loss, and death. An alarming one-third of kidney transplant patients experience medication non-adherence even though the problem is preventable. Existing adherence interventions have proven marginally effective for those with acute and chronic illnesses and ineffective for adult kidney transplant recipients.
READ MORE
Kidney International
Disparities in outcomes for African American kidney transplant recipients have persisted for 40 years without a comprehensive analysis of evolving trends in the risks associated with this disparity. Here we analyzed U.S. transplant registry data, which included adult Caucasian or AA solitary kidney recipients undergoing transplantation between 1990 and 2009 comprising 202,085 transplantations.
READ MORE
Annals of Pharmacotherapy
Medication regimen complexity describes multiple characteristics of a patient’s prescribed drug regimen. Heart transplant recipients must comply with a lifelong regimen that consists of numerous medications. However, a systematic assessment of medication regimen complexity over time has not been conducted in this, or any other, transplant population.
READ MORE
American Journal of Transplantation
Primary graft dysfunction (PGD) is a principal cause of early morbidity and mortality after lung transplantation, but its pathogenic mechanisms are not fully clarified. Thus far, studies using standard clinical assays have not linked microbial factors to PGD. We previously used comprehensive metagenomic methods to characterize viruses in lung allografts greater than 1 month post-transplant and found that levels of Anellovirus, mainly Torque teno viruses (TTV), were significantly higher than in non-transplant healthy controls.
READ MORE
Liver Transplantation
Recurrence of hepatitis C virus (HCV) after liver transplantation (LT) can rapidly lead to liver graft cirrhosis and, therefore, graft failure and retransplantation or death. The aim of the present study was to assess efficacy and tolerance of sofosbuvir (SOF)–based regimens for the treatment of HCV recurrence in patients with severe fibrosis after LT. The Compassionate Use of Protease Inhibitors in Viral C Liver Transplantation (CULPIT) study is a prospective multicenter cohort including patients with HCV recurrence following LT treated with second generation direct antivirals.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
